News
Important Only
HUGE News: Hims & Hers Adds Cancer Testing to Labs Offering
Hims & Hers (NYSE: HIMS) announced today the launch of an early detection cancer test, bringing more value to its lab business. This is another product launch that isn't about pushing pills or slotting into the existing insurance ecosystem; it's fundamentally disruptive to the medical industry. In t...The Motley Fool
Wed, Feb 4
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
Key PointsEli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of its weight loss shots to market.Pfizer is playing catch-up in the GLP-1 space, but it has a long history of innovation.10 stocks we like better than Pfizer › Eli Lilly's (NYSE: LLY) share price jumped 3...The Motley Fool
Wed, Feb 4
AbbVie forecasts upbeat 2026 profit, but shares fall on key drug's sales miss
AbbVie expects $31.6 billion from Rinvoq, Skyrizi in 2026Shares fall 6% after Rinvoq's Q4 sales missSkyrizi sales surpass expectations with $5.01 billionBy Puyaan Singh and Christy Santhosh Feb 4 (Reuters) - AbbVie ABBV.N forecast 2026 profit above Wall Street estimates on Wednesday after the...Reuters
Wed, Feb 4
Could Buying American Express (AXP) Today Set You Up for Life?
Key PointsAmerican Express outperformed the market over the past decade.It is well-insulated from interest rate swings.It faces near-term challenges, but its stock looks reasonably valued.10 stocks we like better than American Express › American Express' (NYSE: AXP) stock has rallied nearly 550% ove...The Motley Fool
Wed, Feb 4
Union Pacific, Wabtec gain on $1.2 billion locomotive deal
Shares of railroad operator Union Pacific UNP.N rise 3.3% to $249.60UNP signs $1.2 billion agreement with locomotive parts maker Wabtec WAB.N to modernize railroad co's AC4400 locomotivesWAB shares up 2.9% at $243.10 after deal announcementUNP will have more than 1,700 modernized locomotives in ...Reuters
Wed, Feb 4
Lilly sees strong growth in 2026 as weight-loss drug rival Novo slips
Profit and revenue forecasts for 2026 well above Street viewLilly's Q4 profit and revenue exceed expectationsLilly's obesity drug Zepbound boosts sales despite price cutsLilly's orforglipron pill under FDA review, decision expected in AprilBy Mrinalika Roy and Mariam Sunny Feb 4 (Reut...Reuters
Wed, Feb 4
Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?
Key PointsJohnson & Johnson's growth rate improved this past year, and that trend is likely to continue.The company sees a lot of growth ahead, particularly in its oncology business.10 stocks we like better than Johnson & Johnson › Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare compa...The Motley Fool
Wed, Feb 4
IDEX Corp rises after quarterly profit and revenue beat
Shares of industrial equipment maker IDEX Corp IEX.N up 3% at $208.17 in morning tradingCo beats Q4 profit and revenue estimates; however, forecasts annual profit below estimates, weighed down by poor demand for industrial equipmentExpects 2026 adjusted EPS between $8.15 and $8.35, whose midpoint is...Reuters
Wed, Feb 4
C WorldWide Group Loads Up 45,000 MercadoLibre Shares Worth $94 Million
Key PointsIncreased MELI stake by 44,747 shares; estimated transaction value of $93.99 million based on quarterly average pricing.Quarter-end position value rose by $87.34 million, reflecting both trading activity and stock price movement.Estimated trade equaled 1.64% of C WorldWide Group's reportab...The Motley Fool
Wed, Feb 4
CANADA STOCKS-TSX struggles for direction as tech worries loom
TSX flatEnergy gains on renewed U.S.-Iran tensionTech selloff extendsATS climbs 8.2% after resultsBy Utkarsh Hathi Feb 4 (Reuters) - Canada's main stock index struggled for direction on Wednesday, as an ongoing technology selloff, driven by AI-related worries weighing on software firms glo...Reuters
Wed, Feb 4
BREAKINGVIEWS-Nvidia’s $100 bln pivot disturbs AI money-go-round
By Karen Kwok LONDON, Feb 4 (Reuters Breakingviews) - The vast sums flowing around the artificial intelligence industry at times recall the ouroboros - the ancient symbol depicting a dragon eating its own tail. Tech giants and startups like OpenAI are snapping up Nvidia's NVDA.O advanced proc...Reuters
Wed, Feb 4
